LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2015 - 2026)
LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -54.61% |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | -79.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.88% |
| Dec 31, 2025 | 67.02% |
| Sep 30, 2025 | 121.65% |
| Jun 30, 2025 | 70.62% |
| Mar 31, 2025 | 211.14% |
| Dec 31, 2024 | 141.68% |
| Sep 30, 2024 | 654.08% |
| Jun 30, 2024 | 120.40% |
| Mar 31, 2024 | 686.48% |
| Dec 31, 2023 | -539.34% |
| Sep 30, 2023 | 102.85% |
| Jun 30, 2023 | -46.84% |
| Mar 31, 2023 | -114.38% |
| Dec 31, 2022 | -122.58% |
| Sep 30, 2022 | -820.74% |
| Jun 30, 2022 | 200.52% |
| Mar 31, 2022 | 439.07% |
| Dec 31, 2021 | 124.44% |
| Sep 30, 2021 | 380.99% |
| Jun 30, 2021 | 25.05% |